These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 29733645)

  • 1. Aromatic-Based Design of Highly Active and Noncalcemic Vitamin D Receptor Agonists.
    Gogoi P; Seoane S; Sigüeiro R; Guiberteau T; Maestro MA; Pérez-Fernández R; Rochel N; Mouriño A
    J Med Chem; 2018 Jun; 61(11):4928-4937. PubMed ID: 29733645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, Synthesis, Biological Activity, and Structural Analysis of Novel Des-C-Ring and Aromatic-D-Ring Analogues of 1α,25-Dihydroxyvitamin D
    Seoane S; Gogoi P; Zárate-Ruíz A; Peluso-Iltis C; Peters S; Guiberteau T; Maestro MA; Pérez-Fernández R; Rochel N; Mouriño A
    J Med Chem; 2022 Oct; 65(19):13112-13124. PubMed ID: 36166643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further Studies on the Highly Active Des-C-Ring and Aromatic-D-Ring Analogues of 1α,25-Dihydroxyvitamin D
    Zárate-Ruíz A; Seoane S; Peluso-Iltis C; Peters S; Gregorio C; Guiberteau T; Maestro M; Pérez-Fernández R; Rochel N; Mouriño A
    J Med Chem; 2023 Nov; 66(22):15326-15339. PubMed ID: 37910811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The first locked side-chain analogues of calcitriol (1alpha,25-dihydroxyvitamin D3) induce vitamin D receptor transcriptional activity.
    Pérez-García X; Rumbo A; Larriba MJ; Ordóñez P; Muñoz A; Mouriño A
    Org Lett; 2003 Oct; 5(22):4033-6. PubMed ID: 14572242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lithocholic acid-based design of noncalcemic vitamin D receptor agonists.
    Gaikwad S; González CM; Vilariño D; Lasanta G; Villaverde C; Mouriño A; Verlinden L; Verstuyf A; Peluso-Iltis C; Rochel N; Berkowska K; Marcinkowska E
    Bioorg Chem; 2021 Jun; 111():104878. PubMed ID: 33853023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiproliferative Activity of Non-Calcemic Vitamin D Analogs on Human Melanoma Lines in Relation to VDR and PDIA3 Receptors.
    Wasiewicz T; Piotrowska A; Wierzbicka J; Slominski AT; Zmijewski MA
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30200275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and biological properties of seco-d-ring modified 1α,25-dihydroxyvitamin D
    Szybinski M; Sektas K; Sicinski RR; Plum LA; Frelek J; DeLuca HF
    J Steroid Biochem Mol Biol; 2017 Jul; 171():144-154. PubMed ID: 28285018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of 1α,25-dihydroxyvitamin D₃ analogues with a long side chain at C12 and short C17 side chains.
    Carballa DM; Seoane S; Zacconi F; Pérez X; Rumbo A; Alvarez-Díaz S; Larriba MJ; Pérez-Fernández R; Muñoz A; Maestro M; Mouriño A; Torneiro M
    J Med Chem; 2012 Oct; 55(20):8642-56. PubMed ID: 22989379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structures of the vitamin D nuclear receptor liganded with the vitamin D side chain analogues calcipotriol and seocalcitol, receptor agonists of clinical importance. Insights into a structural basis for the switching of calcipotriol to a receptor antagonist by further side chain modification.
    Tocchini-Valentini G; Rochel N; Wurtz JM; Moras D
    J Med Chem; 2004 Apr; 47(8):1956-61. PubMed ID: 15055995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene regulatory potential of nonsteroidal vitamin D receptor ligands.
    Peräkylä M; Malinen M; Herzig KH; Carlberg C
    Mol Endocrinol; 2005 Aug; 19(8):2060-73. PubMed ID: 15860548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new class of vitamin D analogues that induce structural rearrangement of the ligand-binding pocket of the receptor.
    Inaba Y; Yoshimoto N; Sakamaki Y; Nakabayashi M; Ikura T; Tamamura H; Ito N; Shimizu M; Yamamoto K
    J Med Chem; 2009 Mar; 52(5):1438-49. PubMed ID: 19193059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and characterization of noncalcemic, tissue-selective, nonsecosteroidal vitamin D receptor modulators.
    Ma Y; Khalifa B; Yee YK; Lu J; Memezawa A; Savkur RS; Yamamoto Y; Chintalacharuvu SR; Yamaoka K; Stayrook KR; Bramlett KS; Zeng QQ; Chandrasekhar S; Yu XP; Linebarger JH; Iturria SJ; Burris TP; Kato S; Chin WW; Nagpal S
    J Clin Invest; 2006 Apr; 116(4):892-904. PubMed ID: 16528410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D receptor 2016: novel ligands and structural insights.
    Maestro MA; Molnár F; Mouriño A; Carlberg C
    Expert Opin Ther Pat; 2016 Nov; 26(11):1291-1306. PubMed ID: 27454349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular evaluation of vitamin D3 receptor agonists designed for topical treatment of skin diseases.
    Bury Y; Ruf D; Hansen CM; Kissmeyer AM; Binderup L; Carlberg C
    J Invest Dermatol; 2001 May; 116(5):785-92. PubMed ID: 11348471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of 1α,25-dihydroxyvitamin D3 analogues with aromatic side chains attached at C-17.
    Liu C; Zhao GD; Mao X; Suenaga T; Fujishima T; Zhang CM; Liu ZP
    Eur J Med Chem; 2014 Oct; 85():569-75. PubMed ID: 25127149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-based design of a superagonist ligand for the vitamin D nuclear receptor.
    Hourai S; Rodrigues LC; Antony P; Reina-San-Martin B; Ciesielski F; Magnier BC; Schoonjans K; Mouriño A; Rochel N; Moras D
    Chem Biol; 2008 Apr; 15(4):383-92. PubMed ID: 18420145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-clinical evidence and clinical translation of benign prostatic hyperplasia treatment by the vitamin D receptor agonist BXL-628 (Elocalcitol).
    Maggi M; Crescioli C; Morelli A; Colli E; Adorini L
    J Endocrinol Invest; 2006; 29(7):665-74. PubMed ID: 16957418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D Analogues Tacalcitol and Calcipotriol Inhibit Proliferation and Migration of T98G Human Glioblastoma Cells.
    Emanuelsson I; Wikvall K; Friman T; Norlin M
    Basic Clin Pharmacol Toxicol; 2018 Aug; 123(2):130-136. PubMed ID: 29575677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic uses of vitamin D analogues.
    Brown AJ
    Am J Kidney Dis; 2001 Nov; 38(5 Suppl 5):S3-S19. PubMed ID: 11689383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological activity of CD-ring modified 1alpha,25-dihydroxyvitamin D analogues: C-ring and five-membered D-ring analogues.
    Verstuyf A; Verlinden L; van Etten E; Shi L; Wu Y; D'Halleweyn C; Van Haver D; Zhu GD; Chen YJ; Zhou X; Haussler MR; De Clercq P; Vandewalle M; Van Baelen H; Mathieu C; Bouillon R
    J Bone Miner Res; 2000 Feb; 15(2):237-52. PubMed ID: 10703925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.